Dr. Robert N. Wolfe, M.D.
Pulmonology (Pulmonary Disease Physician)
8631 W 3rd St, Suite 965w
Los Angeles, CA 90048
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of California, Geffen School of Medicine (1975)
- Years since graduation
- 51
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 939
Licensed in California since 1976, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1975Medical school: University of California, Geffen School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
CA license G32286 (first issued 1976; current) -
Critical Care Medicine (Internal Medicine) Physician
CA license G32286 (first issued 1976; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cedars-Sinai Medical Center Los Angeles, CA
- Cedar-Sinai Marina Del Rey Hospital Marina Del Rey, CA
Medical groups
- Cedars-Sinai Medical Care Foundation (1,692 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 939
- Services billed
- 3,561
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,207 | 665 |
| Test to measure expiratory airflow and volume | 1,047 | 658 |
| Established patient office or other outpatient visit, 20-29 minutes | 378 | 288 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 331 | 59 |
| Test to measure the level of nitric oxide gas | 165 | 165 |
| New patient office or other outpatient visit, 45-59 minutes | 113 | 113 |
| Established patient office or other outpatient visit, 40-54 minutes | 111 | 100 |
| Telephone medical discussion with physician, 21-30 minutes | 103 | 88 |
| Evaluation of use of breathing device | 81 | 78 |
| Injection of drug or substance under skin or into muscle | 71 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Los Angeles, CA | 665 |
| Prednisone Other prescribers in Los Angeles, CA | 389 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Los Angeles, CA | 343 |
| Azithromycin Other prescribers in Los Angeles, CA | 266 |
| Montelukast Sodium Other prescribers in Los Angeles, CA | 234 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Los Angeles, CA | 220 |
| Qvar Redihaler (beclomethasone dipropionate) | 168 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Los Angeles, CA | 150 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Los Angeles, CA | 136 |
| Dupixent Pen (dupilumab) Other prescribers in Los Angeles, CA | 110 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $17.84 in total to this clinician.
| Saluda Medical Americas, Inc. | $17.84 |
|---|
| Food and Beverage | $17.84 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $241,767 in research payments for these studies, mostly to the institutions running them.
- ALTA - Albuterol budesonide Treatment in Acute airway obstruction his is a multi-center randomized double-blind 2-period cross-over study evaluating efficacy and safety of repeated doses of PT027 albuterol budesonide …
AstraZeneca Pharmaceuticals LP - A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough
Genentech, Inc. - Verona
Verona Pharma, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.